Pharmacokinetics of 3TC (GR109714X) Administered With and Without Food to HIV-infected Patients
- 1 August 1993
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 6 (2) , 70-74
- https://doi.org/10.1007/bf03258455
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infectionAIDS, 1992
- Cellular metabolism of (−) enantiomeric 2′-deoxy-3′-thiacytidineBiochemical Pharmacology, 1992
- The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitroAntimicrobial Agents and Chemotherapy, 1992
- Food-induced reduction in bioavailability of didanosineClinical Pharmacology & Therapeutics, 1991
- Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a mealEuropean Journal of Clinical Pharmacology, 1991
- Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat mealAIDS, 1990
- Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.Journal of Clinical Investigation, 1985